About BAROnova
BAROnova is a company based in Goleta (United States) founded in 2006. BAROnova has raised $77.8 million across 4 funding rounds from investors including Boston Scientific, Allergan and Longitude Capital. The company has 1 employees as of December 31, 2021. BAROnova operates in a competitive market with competitors including Apollo Endo, USGI Medical, ReShape, Vibrynt and Satiety, among others.
- Headquarter Goleta, United States
- Employees 1 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Baronova, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$77.8 M (USD)
in 4 rounds
-
Latest Funding Round
$36.5 M (USD), Series D
Nov 23, 2015
-
Investors
Boston Scientific
& 8 more
-
Employee Count
1
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BAROnova
BAROnova has successfully raised a total of $77.8M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $36.5 million completed in November 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BAROnova
BAROnova has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Allergan and Longitude Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life science sector
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early stage VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for BAROnova
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BAROnova
Investment portfolio details for BAROnova
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BAROnova
Detailed financials for BAROnova
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Baronova Comparisons
Peer comparison for BAROnova
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BAROnova
BAROnova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apollo Endo, USGI Medical, ReShape, Vibrynt and Satiety, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices for obesity and GI disorders are developed.
|
|
| Locked | Locked | Locked |
Incisionless operating platform for weight loss surgery
|
|
| Locked | Locked | Locked |
A dual intra-gastric balloon system is provided for weight loss.
|
|
| Locked | Locked | Locked |
Provides durable coat hooks and storage solutions for home use.
|
|
| Locked | Locked | Locked |
Develops a device for transoral gastroplasty to induce satiety through endoscopic methods.
|
|
| Locked | Locked | Locked |
Restrictive gastric implants and procedures are developed to induce satiety.
|
Detailed competitors of BAROnova
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Baronova
Complete news archive for BAROnova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BAROnova
BAROnova was founded in 2006.
BAROnova is headquartered in Goleta, United States. It is registered at Goleta, California, United States.
Hugh Narciso is the current CEO of BAROnova.
BAROnova is a funded company, having raised a total of $77.8M across 4 funding rounds to date.
As of Dec 31, 2021, the latest employee count at BAROnova is 1.
BAROnova was founded in 2006 in Goleta, United States, as a clinical-stage medical-device company. Focus is placed on non-surgical interventions for weight management within the healthcare sector. The TransPyloric Shuttle is designed for endoscopic placement in the stomach to promote satiety and delay gastric emptying. Operations involve device development and clinical trials, with FDA approval pending for the product.
BAROnova's top competitors include Apollo Endo, ReShape and USGI Medical.
BAROnova has 9 investors. Key investors include Boston Scientific, Allergan, Longitude Capital, Sante Ventures, and ONSET Ventures.